We observed uniformly higher expression levels of AMPKα1 in patients’ samples and CRC cell lines than in nontumorous samples and normal cell lines; while the expression levels of AMPKα2 were quite low in patients’ samples. This evidence concerns the gene PRKAA1 and colorectal carcinoma.